TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 299 filers reported holding TANDEM DIABETES CARE INC in Q4 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $221,783 | +2.2% | 4,934 | +8.9% | 0.00% | 0.0% |
| Q3 2022 | $217,000 | -19.6% | 4,532 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $270,000 | -63.3% | 4,560 | -27.9% | 0.00% | -50.0% |
| Q1 2022 | $735,000 | -33.4% | 6,325 | -13.7% | 0.00% | 0.0% |
| Q4 2021 | $1,103,000 | +58.0% | 7,332 | +25.4% | 0.00% | 0.0% |
| Q3 2021 | $698,000 | +215.8% | 5,847 | +158.1% | 0.00% | +100.0% |
| Q2 2021 | $221,000 | +5.2% | 2,265 | -30.6% | 0.00% | -50.0% |
| Q1 2020 | $210,000 | -53.6% | 3,265 | -57.0% | 0.00% | 0.0% |
| Q4 2019 | $453,000 | +20.2% | 7,601 | +19.0% | 0.00% | 0.0% |
| Q3 2019 | $377,000 | +8.3% | 6,387 | +18.4% | 0.00% | 0.0% |
| Q2 2019 | $348,000 | -1.1% | 5,395 | -2.7% | 0.00% | 0.0% |
| Q1 2019 | $352,000 | +72.5% | 5,545 | +3.1% | 0.00% | +100.0% |
| Q4 2018 | $204,000 | -23.6% | 5,378 | -13.8% | 0.00% | -50.0% |
| Q3 2018 | $267,000 | – | 6,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |